NCT02318602: Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
- State
- Completed
- Phase
- Phase 3
- People
- 52 taking part
- Started
- 8 Jan 2016
- Primary completion
- 22 Jun 2017
- Arms
- Infants, Children, Adolescents
- Results
- Posted on the registry
- 17 Dec 2014: Trial registered
- 8 Jan 2016: Trial started
- 22 Jun 2017: Trial completed
- 26 Jul 2018: Trial results posted